Institute for Science and Human Values

Institute for Science and Human Values
Name	Institute for Science and Human Values
Formation	20XX
Type	Nonprofit research institute
Headquarters	City, Country
Leader title	Director

Institute for Science and Human Values is a nonprofit research institute that examines ethical, social, and policy implications of scientific and technological developments. It fosters interdisciplinary dialogue among scholars, policymakers, industry leaders, and civil society actors to address controversies in biomedical research, artificial intelligence, climate science, and biosecurity. The institute engages with international bodies, academic centers, and advocacy organizations to translate research into practice.

History

The institute was founded in the early 21st century amid debates sparked by controversies such as the Human Genome Project, the Asilomar Conference on Recombinant DNA, and controversies surrounding the Tuskegee Syphilis Study. Early advisory board members included figures associated with National Institutes of Health, World Health Organization, and the Royal Society. Its formative years coincided with policy shifts influenced by events like the Bhopal disaster, the Chernobyl disaster, and the adoption of the Convention on Biological Diversity. The institute developed collaborations with universities including Harvard University, University of Oxford, Stanford University, Massachusetts Institute of Technology, and University of Cambridge, and with think tanks such as the Brookings Institution and the Carnegie Endowment for International Peace. Milestones included organizing symposia in the tradition of the Berggruen Institute and convening panels similar to the National Academies of Sciences, Engineering, and Medicine. It has been cited in policy debates alongside actors like European Commission, United Nations, and G7 summits.

Mission and Objectives

The institute states objectives reflecting precedents set by institutions such as the Hastings Center, the Kennedy Institute of Ethics, the Salk Institute for Biological Studies, and the Wellcome Trust. Core aims include promoting responsible conduct in fields influenced by institutions like Cold Spring Harbor Laboratory, encouraging governance frameworks comparable to those debated at the Nuffield Council on Bioethics, and informing policy processes related to initiatives similar to Paris Agreement negotiations. It seeks to integrate perspectives from scholars affiliated with Columbia University, Yale University, Princeton University, University of Chicago, and University of California, Berkeley into advisory reports for bodies such as the European Medicines Agency and Food and Drug Administration.

Programs and Activities

Programs mirror activities undertaken by organizations like Amnesty International, Greenpeace, Human Rights Watch, and Physicians for Human Rights but focused on the intersection of science and values. Major programs include ethics workshops modeled after Davos roundtables, fellowships akin to those at the Kavli Foundation, and public engagement series similar to events at the Tate Modern or the Smithsonian Institution. Activities include policy briefings for institutions like the World Economic Forum, curricular development with partners such as Coursera and edX, and convenings with stakeholders from Siemens, Google, Microsoft, Pfizer, and Moderna. The institute organizes conferences that attract participants from the United Nations Educational, Scientific and Cultural Organization, International Committee of the Red Cross, and the Bill & Melinda Gates Foundation.

Publications and Research

Research outputs draw on methods and topics explored by journals and publishers including Nature, Science, The Lancet, Cell, and PLOS. The institute produces policy reports comparable to those issued by RAND Corporation and white papers similar to World Bank publications. Its scholars publish analyses referencing case studies involving Ebola epidemic, COVID-19 pandemic, Zika virus outbreak, and technological controversies surrounding CRISPR, deep learning, and autonomous vehicles. Peer-reviewed articles have appeared alongside contributions from researchers at Johns Hopkins University, Imperial College London, Karolinska Institute, and ETH Zurich. The institute also issues commentaries aligning with debates seen in publications like Foreign Affairs, The New York Times, and The Guardian.

Organizational Structure and Leadership

The institute's governance includes a board with members drawn from institutions such as United Nations, European Parliament, NATO, and national academies including the Royal Society and the National Academy of Sciences. Leadership roles have been held by scholars connected to Princeton University, Yale University, Columbia University, Stanford University, and University College London. Advisory councils include ethicists, scientists, and legal scholars from Harvard Medical School, Oxford University Press contributors, and former officials from Centers for Disease Control and Prevention, National Science Foundation, and European Centre for Disease Prevention and Control. Operational units mirror structures seen at Ford Foundation program offices and Rockefeller Foundation initiatives.

Funding and Partnerships

Funding sources include philanthropic foundations analogous to the Wellcome Trust, Gates Foundation, Rockefeller Foundation, and corporate partnerships with firms such as Google DeepMind, IBM, Amazon Web Services, and pharmaceutical companies including GlaxoSmithKline and Johnson & Johnson. Grants have been received from governmental agencies like National Institutes of Health, European Research Council, and bilateral programs involving United States Agency for International Development and UK Research and Innovation. Collaborative research projects have involved universities including McGill University, University of Toronto, Peking University, Tsinghua University, and policy institutes such as Chatham House and Center for Strategic and International Studies.

Impact and Criticism

The institute has influenced policy debates on biomedical ethics, data governance, and climate science, cited in deliberations by World Health Assembly, Intergovernmental Panel on Climate Change, and national legislatures such as the United States Congress and the European Parliament. Its convenings have shaped standards referenced by the International Committee of Medical Journal Editors and guidelines similar to those from the Declaration of Helsinki and the Nuremberg Code. Critics compare its influence to controversies faced by entities like Monsanto and question ties to corporate partners including Bayer and Pfizer, expressing concerns similar to debates around industry-funded research in cases involving Tobacco industry disclosures and conflicts highlighted in investigations like those involving GlaxoSmithKline and Theranos. Debates over transparency and independence echo disputes seen at World Bank programs and inquiries such as the Leveson Inquiry.

Category:Research institutes